ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.
Storage: 2-8C
Application: Quality Control TestingEvaluated by Western Blotting in Rat brain tissue lysate.Western Blotting Analysis: A 1:1,000 dilution of this antibody detected CNTNAP2 in Rat brain tissue lysate.Tested ApplicationsWestern Blotting Analysis: A 1:1,000 dilution from a representative lot detected CNTNAP2 in Human brain tissue lysate.Affinity Binding Assay:: A representative lot of this antibody bound CNTNAP2 peptide with a KD of 3.7 x 10-8 in an affinity binding assay.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected CNTNAP2 in human cerebral cortex tissue sections.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany